EMD Serono is the biopharmaceutical division of Merck KGaA, a leading science and technology company. With a focus on developing innovative therapies in the areas of neurology, oncology, fertility, and endocrinology, EMD Serono is committed to improving the lives of patients worldwide. Through their research and development efforts, EMD Serono has brought many groundbreaking treatments to market and continues to push the boundaries of what is possible in the field of biopharmaceuticals.
Telephone +44(0)1284 728659
Email [email protected]